Clinical Trials
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer
— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...
June 24, 2024 | News
Novo Nordisk's FRONTIER2 Trial: Up to 95% of cPatients Achieve Zero Bleeds on Mim8
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had no prior prophylaxis treatment, experienced zero treated bleeds while on Mim...
June 24, 2024 | News
Gilead Sciences Announces 100% Efficacy in Phase 3 PURPOSE 1 Trial for HIV Prevention in Cisgender Women
Gilead Sciences, Inc. announced topline results from an interim analysis of its pivotal Phase 3 PURPOSE 1 trial, demonstrating that the company’s twi...
June 21, 2024 | News
Enveda Biosciences Secures $55 Million in Latest Financing Round
Enveda Biosciences a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to ...
June 17, 2024 | News
SciRhom GmbH Secures Approval for Clinical Trial Application of SR-878 in Austria
SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic antibodies, announced the approval of a clinical trial a...
June 14, 2024 | News
IQVIA Launches One Home for Sites™ to Streamline Clinical Trial Management
IQVIA announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for the key systems...
June 13, 2024 | News
GC Biopharma and Novel Pharma Receive FDA Fast Track Designation for Sanfilippo Syndrome Treatment GC1130A
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfili...
June 11, 2024 | News
DeepQure Initiates Early Feasibility Study for Groundbreaking HyperQure™ System Following FDA Approval
DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), announce...
June 11, 2024 | News
Vertex's TRIKAFTA® Shows Significant Clinical Benefits in Cystic Fibrosis Patients with Rare Mutations
Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations s...
June 10, 2024 | News
MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease
MLB (Merry Life Biomedical Company, Ltd., Taiwan ) a biomedical company, announced that the U.S. Food and Drug Administration (FDA) h...
June 07, 2024 | News
Shanghai MicuRx Achieves Key Milestone in Combatting Drug-Resistant Infections with Successful Phase I Trial of MRX-8
According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant b...
June 07, 2024 | News
I-Mab Partners with Bristol Myers Squibb for Phase 1 Clinical Trial of Novel Cancer Therapy
I-Mab , a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapi...
June 06, 2024 | News
Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...
June 03, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
